27.06.2023 - Mike Sherman to Transition to Chair of the Board of Directors Martha Demski to Assume Role of Lead Independent Director DURHAM, N.C., June 27, 2023 (GLOBE NEWSWIRE) - Chimerix, Inc. (NASDAQ:CMRX), a biopharmaceutical company whose mission it is . Seite 1
Chimerix, Inc. (CMRX), a biotech known for its smallpox therapy Tembexa added ~7% pre-market Thursday after its Q3 2022 results as the company updated on the regulatory path.